Gilead Sciences
GILD
#95
Rank
NZ$311.45 B
Marketcap
NZ$250.88
Share price
-1.47%
Change (1 day)
23.14%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): NZ$17.01 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.08 Billion. In 2024 the company made an earning of NZ$1.17 Billion a decrease over its 2023 earnings that were of NZ$11.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$17.01 B1353.4%
2024 NZ$1.17 B-89.94%
2023 NZ$11.64 B17.97%
2022 NZ$9.86 B-29.77%
2021 NZ$14.04 B395.99%
2020 NZ$2.83 B-67.66%
2019 NZ$8.75 B-33.84%
2018 NZ$13.23 B-42.35%
2017 NZ$22.96 B-20.87%
2016 NZ$29.01 B-21.06%
2015 NZ$36.75 B45.8%
2014 NZ$25.21 B253.01%
2013 NZ$7.14 B16.51%
2012 NZ$6.12 B-1.07%
2011 NZ$6.19 B-6.71%
2010 NZ$6.64 B11.75%
2009 NZ$5.94 B29.5%
2008 NZ$4.58 B19.11%
2007 NZ$3.85 B-455.74%
2006 -NZ$1.09 Billion-154.93%
2005 NZ$1.97 B76.99%
2004 NZ$1.11 B-266.16%
2003 -NZ$0.68 Billion-638.24%
2002 NZ$0.12 B31.5%
2001 NZ$94.72 M-242.15%
2000 -NZ$66.65 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$84.52 Million8.73%
1997 -NZ$77.73 Million27.22%
1996 -NZ$61.1 Million
1994 -NZ$58.22 Million26.57%
1993 -NZ$46 Million46.49%
1992 -NZ$31.4 Million362.5%
1991 -NZ$6.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.97 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.11 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.81 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.19 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.99 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.23 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.68 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$7.57 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.18 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA